Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report. | Ital J Pediatr | 2022 | 36221102 | PubTator, text mining | PubMed |
| Fluorinated derivatives of tetrahydroaltersolanol molecule on COVID-19, HIV, and HTLV protease by DFT and molecular docking approaches. | J Mol Model | 2022 | 36217060 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients. | Front Oncol | 2022 | 36212461 | PubTator, text mining | PubMed |
| Genetic influence on brain volume alterations related to self-reported childhood abuse. | Front Neurosci | 2022 | 36203798 | PubTator, text mining | PubMed |
| Domain Evolution of Vertebrate Blood Coagulation Cascade Proteins. | J Mol Evol | 2022 | 36181519 | PubTator, text mining | PubMed |
| Frozen and freeze-dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality. | Transfusion | 2022 | 36181447 | PubTator, text mining | PubMed |
| Stroke genetics informs drug discovery and risk prediction across ancestries. | Nature | 2022 | 36180795 | PubTator, text mining | PubMed |
| Anticoagulation polyvinyl chloride extracorporeal circulation catheters for heparin-free treatment. | J Mater Chem B | 2022 | 36165336 | PubTator, text mining | PubMed |
| Using Postoperative Coagulation Parameters Within 24 h After Liver Transplantation to Predict Incidence of Stage 3 Acute Kidney Injury (AKI). | Ann Transplant | 2022 | 36164260 | PubTator, text mining | PubMed |
| Urinary extracellular vesicles carry multiple activators and regulators of coagulation. | Front Cell Dev Biol | 2022 | 36158187 | PubTator, text mining | PubMed |
| Cross-GWAS coherence test at the gene and pathway level. | PLoS Comput Biol | 2022 | 36156592 | PubTator, text mining | PubMed |
| Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors. | Circulation | 2022 | 36154123 | PubTator, text mining | PubMed |
| Bleeding and Thrombotic Issues during Extracorporeal Membrane Oxygenation. | J Clin Med | 2022 | 36143022 | PubTator, text mining | PubMed |
| Strategies for Therapeutic Amelioration of Aberrant Plasma Zn2+ Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects. | Int J Mol Sci | 2022 | 36142215 | PubTator, text mining | PubMed |
| Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1. | Int J Mol Sci | 2022 | 36142125 | PubTator, text mining | PubMed |
| Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure. | Science | 2022 | 36137043 | PubTator, text mining | PubMed |
| Cytotoxic Drimane-Type Sesquiterpenes from Co-Culture of the Marine-Derived Fungi Aspergillus carneus KMM 4638 and Beauveria felina (=Isaria felina) KMM 4639. | Mar Drugs | 2022 | 36135773 | PubTator, text mining | PubMed |
Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis. | J Thromb Haemost | 2022 | 36128769 | PubTator, text mining | PubMed |
| Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures. | J Thromb Haemost | 2022 | 36128757 | PubTator, text mining | PubMed |
| Congenital coagulation factor V deficiency with intracranial hemorrhage. | J Clin Lab Anal | 2022 | 36125894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=33